Abstract
The purpose of the study was to validate a recently proposed new grading system for ocular manifestations of chronic graft-versus-host disease (cGVHD). Diagnosis of cGVHD was based on the NIH consensus criteria. In addition, a grading scale was applied, which has been developed by the German-Austrian-Swiss Consensus Conference on Clinical Practice in cGVHD. Sixty-six patients (male n = 46, female n = 20, mean age 48 years) with ocular cGVHD were included. Application of the proposed Consensus Conference grading revealed inflammatory activity in all patients with mild (33 %), moderate (44 %), or severe inflammation (23 %). Clinical scoring by the NIH scoring system showed that 6 % of patients had mild symptoms; 59 % of patients had moderate dry eye symptoms partially affecting activities of daily living, without vision impairment; and 35 % of patients had severe dry eye symptoms significantly affecting daily activities. Clinical characterization and grading by the Consensus Conference grading scale revealed that ocular cGVHD (1) frequently leads to severe ocular surface disease based on impaired function of the lacrimal glands and involvement of cornea, conjunctiva, and lids; (2) is mostly associated with ongoing inflammatory activity; (3) often leads to functional impairment and reduced quality of life; and (4) is associated with an increased risk for severe, sight-threatening complications.
Similar content being viewed by others
References
Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373(9674):1550–61
Wolff D, Bertz H, Greinix H, Lawitschka A, Halter J, Holler E (2011) The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany. Austria Switzerland Dtsch Arztbl Int 108(43):732–40
Carlens S, Ringden O, Remberger M, Lönnqvist B, Hägglund H, Klaesson S et al (1998) Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 22:755–61
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al (2011) Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 117(11):3214–3219
Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP et al (2012) Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 47(11):1470–3
Filipovich AH (2008) Diagnosis and manifestations of chronic graft-versus-host disease. Best Pract Res Clin Haematol 21(2):251–7
Kim SK, Dunn J (2009) Chronic ocular graft versus host disease. In: Vogelsang GB, Pavletic SZ (eds) Chronic graft versus host disease: interdisciplinary management. Cambridge University Press, New York, pp 199–206
Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19–27
Kim SK (2006) Update on ocular graft versus host disease. Curr Opin Ophthalmol 17(4):344–8
Ogawa Y, Shimmura S, Kawakita T, Yoshida S, Kawakami Y, Tsubota K (2009) Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol 175:2372–2381
Westekemper H, Meller S, Citak S, Schulte C, Steuhl KP, Homey B et al (2010) Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant 45(8):1340–6
Stevenson W, Shikari H, Saboo US, Amparo F, Dana R (2013) Bilateral corneal ulceration in ocular graft-versus-host disease. Clin Ophthalmol 7:2153–8
Hessen M, Akpek E (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12:540–547
Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–56
Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107:1343–8
Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR et al (2004) Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 33(10):1031–5
Wright JC, Meger GE (1962) A review of the Schirmer test for tear production. Arch Ophthalmol 67:564–5
Lemp MA, Hamill JR Jr (1973) Factors affecting tear film breakup in normal eyes. Arch Ophthalmol 89(2):103–5
Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7):640–50
Carpenter PA, Kitko CL, Elad S et al. (2015) National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report, Biology of Blood and Marrow Transplantation. doi: 10.1016/j.bbmt.2015.03.024.
Bernauer W, Thiel MA, Kurrer M, Heiligenhaus A, Rentsch KM, Schmitt A et al (2006) Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br J Ophthalmol 90(3):285–8
Balaram M, Schaumberg DA, Dana MR (2001) Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 131(1):30–6
Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M et al (2008) Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41:293–302
Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–83
Allan EJ, Flowers ME, Lin MP, Bensinger RE, Martin PJ, Wu MC (2011) Visual acuity and anterior segment findings in chronic graft-versus-host disease. Cornea 30(12):1392–7
Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI et al (2013) International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep 3:3419
Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH, Pidala J, Khera N, Vogelsang GB, Weisdorf D, Martin PJ, Pavletic SZ, Lee SJ (2012) Chronic GVHD Consortium. Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 119(3):487–93
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW et al. (2014) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant
Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A (2010) Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 29(7):758–63
Crews SJ (1963) Posterior subcapsular lens opacities in patients on long-term corticosteroid therapy. Br J Med 1:1644–1647
Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE et al (1984) Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10(7):957–64
Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28(10):1091–6
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Blecha, C., Wolff, D., Holler, B. et al. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD. Ann Hematol 95, 493–499 (2016). https://doi.org/10.1007/s00277-015-2575-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2575-9